Merck KGaA
Change company Symbol lookup
Select an option...
MKGAF Merck KGaA
$NYLGCAPT NYSE U.S. Large Cap Equal Weight Ind
VIVC Vivic Corp
BAC Bank of America Corp
DGRW WisdomTree U.S. Quality Dividend Growth Fund
DFP Flaherty & Crumrine Dynamic Preferred and Income Fund
DFP Flaherty & Crumrine Dynamic Preferred and Income Fund
DES WisdomTree U.S. SmallCap Dividend Fund
DEO Diageo PLC
DDF Delaware Investments Dividend and Income Fund
Go


Based in Germany
Company profile

Merck KGaA is a Germany-based science and technology company. The Company operates in three business segments: Healthcare, Life Sciences and Performance Materials. The Healthcare business, which operates in the United States and Canada as EMD Serono, focuses on such therapeutic areas as allergies, fertility, oncology and neurodegenerative diseases, developing drugs, diagnostic substances and medical devices. The Life Sciences business comprises the activities of MilliporeSigma, which provides solutions that facilitate biotechnology and pharmaceutical research. The product range includes laboratory water systems, gene editing tools, cell lines and end-to-end drug manufacturing systems, among others. The Performance Materials business provides specialty chemicals for various applications, including liquid crystals for electronic displays, materials for integrated circuits, effect pigments for coatings and color cosmetics, as well as functional materials for energy solutions.

Closing Price
$121.95
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
252
0

Display:

Providers:

UpdateCancel
6 providers
June 23, 2020
Lions Bay Mining Announces Execution of Secured Lending Facility with BioVaxys Inc. and Production of Vaccine Candidate for Preclinical Study

Vancouver, British Columbia--(Newsfile Corp. - June 23, 2020) - Lions Bay Mining Corp. (CSE: LBM) (the "Company" or "Lions Bay") is pleased to announce that, following the execution of a Share Exchange Agreement with BioVaxys Inc. ("BioVaxys"), the...(Newsfile)

June 22, 2020
Sutro Biopharma Presents New Preclinical Data at 2020 AACR Virtual Annual Meeting II Suggesting Synergy between its STRO-002 Antibody-Drug Conjugate and Immune Checkpoint Inhibitors Resulting in Tumor Regression and Adaptive Anti-Tumor Immunity

Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation oncology therapeutics, today...(PR Newswire)

June 16, 2020
Intermolecular Announces Breakthrough Four-Element ALD Chalcogenide-based OTS for 3D Memory Arrays

Intermolecular, Inc. ("Intermolecular"), the trusted partner for materials innovation and a wholly-owned subsidiary of Merck KGaA, Darmstadt, Germany, today announced the industry's first quaternary atomic layer deposition (ALD) GeAsSeTe1 OTS device...(PR Newswire)

June 11, 2020
Sugar Alcohol Market to Exhibit a CAGR of 7.75% by 2027; Increasing Preference for Sugar-based Alternatives to Fuel Demand: Fortune Business Insights(TM)

The global Sugar Alcohol market size is projected to reach USD 6.70 Billion by 2027 backed by increasing demand for gluten-free food products across the globe. Fortune Business Insights, in its latest report, titled "Sugar Alcohol Market Size...(Globe Newswire)

June 09, 2020
Sutro Biopharma to Present New Preclinical Data on its STRO-002 Antibody-Drug Conjugate at the Upcoming AACR 2020 Virtual Meeting on June 22, 2020

Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation oncology therapeutics, today...(PR Newswire)

Akcea Appoints New Senior Vice President, Business Development and Corporate Strategy

Akcea Therapeutics, Inc. (NASDAQ: AKCA), a majority-owned affiliate of Ionis Pharmaceuticals, Inc., today announced that Kia Motesharei, Ph.D., has joined the company as Senior Vice President of Business Development & Corporate Strategy. In this...(PR Newswire)

May 29, 2020
New England Journal of Medicine Publishes Primary Analysis of VISION Data for Tepotinib in Advanced NSCLC with METex14 Skipping Alterations

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, today announced that updated data from the ongoing, single-arm Phase II VISION study evaluating tepotinib* as a single agent in patients with advanced...(PR Newswire)

May 28, 2020
Merck KGaA, Darmstadt, Germany, and Twitch Join Forces on World Multiple Sclerosis Day to Connect People Living with MS

-- Merck KGaA, Darmstadt, Germany, and Twitch collaborate on World MS Day to increase understanding of the impact of multiple sclerosis (MS) -- Livestream event with Twitch influencers on May 30 will raise awareness and money for the MS...(PR Newswire)

May 27, 2020
Rebif(R) U.S. Label Now Includes Pregnancy Outcomes and Lactation Information to Help Inform Treatment Decisions for Women with MS

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, announced today the U.S. Food and Drug Administration (FDA) has approved the inclusion of new safety data on pregnancy and breastfeeding in the...(PR Newswire)

Legionella Testing Market to Reach USD 455.99 Million by 2027; Increasing Popularity of PCR Tests Will Augment Growth, says Fortune Business Insights(TM)

The global legionella testing market size is anticipated to gain traction from the increasing prevalence of legionnaire infection. In addition to this, the rapidly spreading pandemic of COVID19 that affects the respiratory system is also propelling...(Globe Newswire)

May 23, 2020
New Late-Breaking Data at EAN Indicate Evobrutinib is the First BTK Inhibitor to Report Efficacy and Safety in MS Over 108 Weeks

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today announced data on the long-term efficacy and safety profile of evobrutinib, an investigational, oral, highly selective Bruton's Tyrosine...(PR Newswire)

May 11, 2020
Blood Group Typing Market to Rise at 7.2% CAGR till 2027; Increasing Demand for Efficient and Economical Blood Grouping Technologies to Boost the Market: Fortune Business Insights(TM)

The global blood group typing market size is projected to reach USD 2.68 billion by 2027, exhibiting a CAGR of 7.2% during the forecast period. Rising prevalence of anemia worldwide is set to fuel the growth of this market, shares Fortune Business...(Globe Newswire)

April 27, 2020
Global Allergy Immunotherapies Market 2020-2024, Featuring Key Vendor Profiles Including Aimmune Therapeutics, DBV Technologies and Merck KGaA - ResearchAndMarkets.com

The "Global Allergy Immunotherapies Market 2020-2024" report has been added to ResearchAndMarkets.com's offering. This report on the global allergy immunotherapies market provides analysis on market size and forecasts trends, growth drivers, and...(BusinessWire)

April 23, 2020
The Global Viral Inactivation Market is expected to grow from USD 523.04 Million in 2018 to USD 1,289.58 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 13.75%

Reportlinker.com announces the release of the report "Global Viral Inactivation Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025...(Globe Newswire)

April 22, 2020
Albumin Market to Reach USD 6.77 Billion by 2026; Rising Usage of Recombinant DNA Technology to Propel Growth: Fortune Business Insights(TM)

The global albumin market is likely to gain traction from the rising usage of recombinant DNA technology to safely produce significant proteins and other components in the laboratory setting. This information is given by Fortune Business...(Globe Newswire)

April 20, 2020
Genome & Company receives FDA IND clearance for GEN-001, its first anti-cancer microbiome therapeutic

Genome & Company (KONEX: 314130), a biotechnology company developing innovative therapeutics in immune-oncology, announced today that the United States (US) Food and Drug Administration (FDA) has accepted the Investigational New Drug (IND)...(PR Newswire)

April 14, 2020
Merck Foundation Announce 'Stay at Home' Media Recognition Awards for Asian Countries

Merck Foundation, the philanthropic arm of Merck KGaA Germany, announced the call for applications for 'Stay at Home' Media Recognition Awards for the journalists in Asian countries. The theme of the awards is 'Raising Awareness on how to Stay Safe...(BusinessWire)

April 09, 2020
Seeqc Gains Over $11 Million in Funding to Introduce Fully Digital Quantum Computing

Seeqc, the Digital Quantum Computing(TM) company, today announced funding of $5 Million from M Ventures, the strategic corporate venture capital arm of Merck KGaA, Darmstadt, Germany to develop commercially viable quantum computing systems for...(BusinessWire)

Roche's Ocrevus Continues to Impress in the EU with Strong Uptake in New Start and Switch Multiple Sclerosis Patient Segments, but Novartis' Mayzent and Ofatumumab May Threaten the Brand's Long-Term Dominance

Driven by expanded access to and uptake of disease-modifying therapies (DMTs) to treat advanced stages of relapsing multiple sclerosis (MS), the MS market in Europe shows signs of continued expansion of the number of patients treated with DMTs...(PR Newswire)

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.